MAM
Vizeum India wins the media mandate for REPCO Home Finance
MUMBAI: The Chennai headquartered, RHFL, promoted by REPCO Bank, a government of India enterprise has appointed Vizeum media as it media AOR (Agency on Record). RHFL is embarking on a growth path and the appointment of Vizeum is seen in line with the same.
Vizeum, launched four years ago in India, has had a very quick ramp up of team, offices, clients, awards and industry recognition. As a profit making, well talked about and recommended agency, it is evident that the company has been making a lot of right moves.
Confirming the appointment of Vizeum, RHFL MD R Varadarajan said, “We are focused on translating into reality the aspirations of people to own a home through credit support customised to suit individual needs in a transparent and ethical way. We have many innovative loan products. We have been fairly successful with a spread of close to 100 operating centers in our focus markets. The vision for our growth required us to get on board domain experts to guide us. Vizeum approached us proactively and the discussions have been on for many months. We are quite satisfied with their knowledge, passion and more importantly the sincere commitment to build our business. Their leadership staying involved in our business is an added benefit. We look forward to working with Vizeum.”
Vizeum managing director – Indian subcontinent S Yesudas said, “It is a matter of pride for us that more and more clients are finding value in associating with Vizeum. It also makes us very humble. We have our task fully cut out for RHFL. We will stay focussed on their business with utmost sincerity, in as selfless manner as possible. We thank the RHFL management for considering us worthy. I take this opportunity to welcome the client into the Vizeum family. This business will be handled out of our Chennai office.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
